High-dose cytosine arabinoside and etoposide: An effective regimen without anthracyclines for refractory childhood acute non-lymphocytic leukemia

Leukemia

Volumn 11, Issue 2, 1997, Pages 185-189

  Whitlock, J A ^a,c   Wells, R J ^b   Hord, J D ^a,d   Janco, R L ^a   Greer, J P ^a   Gay, J C ^a   Edwards, J R ^a   McCurley, T L ^a   Lukens, J N ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

^c VANDERBILT UNIVERSITY   (United States)

^d CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

ANLL; Etoposide; High dose Ara C; Relapse; Salvage therapy

Indexed keywords

ANTHRACYCLINE; CYTARABINE; ETOPOSIDE;

ACUTE NONLYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BACTERIAL INFECTION; BONE MARROW SUPPRESSION; CEREBELLUM DISEASE; CHILD; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; CONJUNCTIVITIS; DIARRHEA; DRUG MEGADOSE; ERYTHRODERMA; FEMALE; FEVER; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKEMIA REMISSION; MAINTENANCE THERAPY; MALE; MAXIMUM PERMISSIBLE DOSE; MUCOSA INFLAMMATION; MYCOSIS; PRIORITY JOURNAL; SALVAGE THERAPY;

EID: 0031052815     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400572     Document Type: Article

References (12)

1. Pui C-H, Crist WM. Biology and treatment of acute lymphoblastic leukemia. ; Pediatr 1994; 124: 491-503.
2. Lampkin BC, Lange B, Bernstein I et al. Biologic characteristics and treatment of acute nonlymphocytic leukemia in children: report of the ANLL Strategy Group of the Childrens Cancer Study Group. Ped Clin N Am 1988; 35: 743-764.
3. Woods WC, Nesbit ME, Ramsay NKC et al. Intensive therapy followed by bone marrow transplantation for patients with acute lymphocytic leukemia in second or subsequent remission. Blood 1983; 61: 1182-1189.
4. Brochstein JA, Kernan NA, Groshen S et al. Allogeneic bone marrow transplantation after hyperfractionated total-body irradiation and cyclophosphamide in children with acute leukemia. New Engl J Med 1987; 317: 1618-1624.
5. Sanders JE, Thomas ED, Buckner CD, Doney K. Marrow transplantation for children with acute lymphoblastic leukemia in second remission. Blood 1987; 70: 324-326.
6. Ash RC, Casper JT, Chitambar CR et al. Successful allogeneic transplantation of T-cell-depleted bone marrow from closely HLA-matched unrelated donors. New Engl J Med 1990; 322: 485-494.
7. Rivera GK, Buchanan G, Boyett JM et al. Intensive treatment of childhood acute lymphoblastic leukemia in first bone marrow relapse: a Pediatric Oncology Group study. New Engl J Med 1986; 315: 273-278.
8. Ramsay N, LeBien T, Nesbit M et al. Autologous bone marrow transplantation for patients with acute lymphoblastic leukemia in second or subsequent remission: results of bone marrow treated with monoclonal antibodies BA-1, BA-2, and BA-3 plus complement. Blood 1985; 66: 508-513.
9. Kersey JH, Weisdorf D, Nesbit ME et al. Comparison of autologous and allogeneic bone marrow transplantation for treatment of high-risk refractory acute lymphoblastic leukemia. New Engl J Med 1987; 317: 461-467.
10. Woods WG, Kobrinsky N, Buckley J et al. Intensively timed induction therapy followed by autologous or allogeneic bone marrow transplantation for children with acute myeloid leukemia or myelodysplastic syndrome. a Childrens Cancer Group pilot study. J Clin Oncol 1993; 11: 1448-1457.
11. Kalwinsky DK, Raimondi SC, Schell MJ et al. Prognostic importance of cytogenetic subgroups in de novo pediatric acute nonlymphocytic leukemia. J Clin Oncol 1990; 8: 75-83.
12. Gaynon PS, Bleyer WA, Steinherz PC et al. Modified BFM therapy for children with previously untreated acute lymphoblastic leukemia and unfavorable prognostic features. Am J Pediatr Hematol/ Oncol 1988; 10: 42-50.